Issue of share options and PDMR dealing
Share options covering 7.4m shares issued to employees following AGM approval at 99.76%.
- Share options issued 7,413,488 shares
- Options granted to CEO (Bram Goorden) 4,448,093 shares at 1 pence
- Options granted to CFO (Grant Nash) 2,965,395 shares at 1 pence
Select text to share a quote on X · sign in to keep highlights & notes in your IXI notes
Issue of share options
7 February 2025 - London, UK. IXICO plc (AIM: IXI, "IXICO" or "the Company") a global leader in neuroscience imaging, using its AI-driven platform to help advance therapy research in neurological disorders, confirms that share option awards covering 7,413,488 shares, which were proposed by, and discussed with, the Company's major shareholders in October 2024 (see: Circular) and approved pursuant to a resolution supported by 99.76% of the shareholder vote at the Annual General Meeting of 24 January 2025 have been issued today.
Full details of the terms of the options were set out in the Notice of AGM (see: AGM resolutions)
Giles Balleny / Dan Hodkinson (Corporate Finance) Nigel Birks (Life Science Specialist Sales) Harriet Ward (Corporate Broking) Michael F Johnson / Tamar Cranford Smith (Sales)
| a) | Name | Bram Goorden |
| 2 | Reason for the notification | |
| a) | Position/status | Chief Executive Officer |
| b) | Initial notification /Amendment | Initial |
| a) | Name | IXICO plc |
| b) | LEI | 2138005M1F59O6HWSA97 |
| a) | Description of the financial instrument, type of instrument | Options over ordinary shares in IXICO plc |
| Identification code | ISIN: GB00BFXR4C20 | |
| b) | Nature of the transaction | Grant of Share Options |
| c) | Price(s) and volume(s) | |
| Price(s) | Volume(s) | |
| 1 pence | 4,448,093 | |
| d) | Aggregated information | |
| N/A - single transaction | ||
| - Aggregated volume | ||
| - Price | ||
| e) | Date of the transaction | 7 February 2025 |
| f) | Place of the transaction | Off Market Transaction |
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Grant Nash |
| 2 | Reason for the notification | |
| a) | Position/status | Chief Financial Officer |
| b) | Initial notification /Amendment | Initial |
| a) | Name | IXICO plc |
| b) | LEI | 2138005M1F59O6HWSA97 |
| a) | Description of the financial instrument, type of instrument | Options over ordinary shares in IXICO plc |
| Identification code | ISIN: GB00BFXR4C20 | |
| b) | Nature of the transaction | Grant of Share Options |
| c) | Price(s) and volume(s) | |
| Price(s) | Volume(s) | |
| 1 pence | 2,965,395 | |
| d) | Aggregated information | |
| N/A - single transaction | ||
| - Aggregated volume | ||
| - Price | ||
| e) | Date of the transaction | 7 February 2025 |
| f) | Place of the transaction | Off Market Transaction |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.